(t-MDS) Research & Outcomes
Sudipto Mukherjee M.D., hematology oncology physician at Cleveland Clinic Discusses (t-MDS) Research & Outcomes At The 60th ASH Annual Meeting on Dec 1, 2018.
Author: ASHReport
Added: 12/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - December 10, 2018 Category: Cancer & Oncology Source Type: podcasts
Azacitidine & Atezolizumab Combo Study
Aaron Gerds, M.D., M.S. assistant professor of medicine in the Hematology and Medical Oncology department at the Cleveland Clinic Taussig Cancer Institute Discusses Azacitidine & Atezolizumab Combo St...
Author: ASHReport
Added: 12/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - December 10, 2018 Category: Cancer & Oncology Source Type: podcasts
Phase 1 Study Of REGN1979
Rajat Bannerji, MD, PhD Associate Professor of Medicine Division of Hematology Oncology Robert Wood Johnson Medical School Rutgers, The State University of New Jersey Discusses Phase 1 Study Of REGN19...
Author: ASHReport
Added: 12/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - December 10, 2018 Category: Cancer & Oncology Source Type: podcasts
Whats On The Horizon For CLL
Jennifer Brown, M.D., Director of the CLL Center of the Division of Hematologic Malignancies at Dana-Farber Cancer Institute and an Associate Professor of Medicine at Harvard Medical School in Boston,...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
What's on the Horizon For CLL
Jennifer Brown, M.D., Director of the CLL Center of the Division of Hematologic Malignancies at Dana-Farber Cancer Institute and an Associate Professor of Medicine at Harvard Medical School in Boston,...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
The Role Of MRD In CLL
Jennifer Brown, M.D., Director of the CLL Center of the Division of Hematologic Malignancies at Dana-Farber Cancer Institute and an Associate Professor of Medicine at Harvard Medical School in Boston,...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Prophylaxis With Pi3 Kinase Inhibitors
Jennifer Brown, M.D., Director of the CLL Center of the Division of Hematologic Malignancies at Dana-Farber Cancer Institute and an Associate Professor of Medicine at Harvard Medical School in Boston,...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Pi3 Kinase Inhibitors, Idelalisib, Duvelisib, & amp; Copanlisib
Jennifer Brown, M.D., Director of the CLL Center of the Division of Hematologic Malignancies at Dana-Farber Cancer Institute and an Associate Professor of Medicine at Harvard Medical School in Boston,...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Pi3 Kinase Inhibitors Autoimmune Toxicity
Jennifer Brown, M.D., Director of the CLL Center of the Division of Hematologic Malignancies at Dana-Farber Cancer Institute and an Associate Professor of Medicine at Harvard Medical School in Boston,...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Duvelisib: New Treatment For Relapse Refractory CLL
Jennifer Brown, M.D., Director of the CLL Center of the Division of Hematologic Malignancies at Dana-Farber Cancer Institute and an Associate Professor of Medicine at Harvard Medical School in Boston,...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
How To Manage 17P Patients
Neil E. Kay, M.D., Professor of Medicine at the Mayo Clinic College of Medicine and a Consultant in the Department of Internal Medicine, Division of Hematology at Mayo Clinic in Rochester, Minnesota d...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Where Is The Field Heading In CLL
Jacqueline Barrientos, M.D., Associate Professor, Division of Hematology and Medical Oncology,<br />Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Discusses Wher...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Where is the Field Heading in CLL?
Jacqueline Barrientos, M.D., Associate Professor, Division of Hematology and Medical Oncology,<br />Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Discusses Wher...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
New Agents In The Pipeline To Treat CLL & WM
Jacqueline Barrientos, M.D., Associate Professor, Division of Hematology and Medical Oncology,<br />Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Discusses New ...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
New Agents in the Pipeline to Treat CLL & amp; WM
Jacqueline Barrientos, M.D., Associate Professor, Division of Hematology and Medical Oncology,<br />Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Discusses New ...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
